Kevin Xu Rejoins Fortune CEO Initiative 2025 List

In December 2025, Fortune magazine unveiled its cross-year issue featuring the Fortune CEO Initiative 2025 list. Kevin Xu, Chairman of the Board of MEBO Group and former Chair of the APEC Host Committee, has once again been selected, reaffirming his standing within one of the world’s most influential and invitation-only communities of global business leaders.

The Fortune CEO Initiative brings together top executives committed to embedding social progress into core business strategy. The platform focuses on key global challenges including sustainable growth, diversity and inclusion, and long-term corporate responsibility. Through annual summits, regional forums, and issue-specific working groups, members exchange best practices, develop solutions, and catalyze collective action. As a flagship Fortune program, the Initiative—alongside the Fortune Global 500 and Fortune Global Forum—serves as a major barometer of global business leadership.

Kevin Xu has been selected for the Fortune CEO Initiative multiple times since 2018. He has actively participated in Fortune Global Forums, the Fortune Global Sustainability Forum, and CEO Initiative Annual Meetings, and has been interviewed by Fortune on multiple occasions, sharing insights on global cooperation, health governance, and responsible corporate leadership.

The 2025 Fortune CEO Initiative list once again features a distinguished group of leaders from Fortune Global 500 companies and industry benchmarks, including CEOs from Salesforce, IBM, Mastercard, Sanofi, Abbott, and HP, spanning technology, finance, healthcare, and manufacturing—reflecting the collective force shaping the future of global business.

 

---

 

About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.